Recurrent Adrenal Gland Pheochromocytoma
3 clinical trials · Condition
◉ Watch Recurrent Adrenal Gland Pheochromocytoma
| Record | Firm | Date |
|---|---|---|
| Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (NCT04284774) | National Cancer Institute (NCI) | 2020-10-13 |
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
| Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma (NCT01340794) | National Cancer Institute (NCI) | 2011-05-01 |
Track Recurrent Adrenal Gland Pheochromocytoma automatically
Every clearance here is in the API, with alerts when new ones post.